iCAD Investor Relations Material
Latest events
Status Update
iCAD
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from iCAD Inc
Access all reports
iCAD Inc. is a medical technology company focused on providing innovative solutions for cancer detection and therapy. The company develops advanced imaging and radiation therapy technologies, including artificial intelligence-based software for early cancer detection, particularly in mammography, and radiation therapy systems for treating cancerous tumors. iCAD’s products aim to improve diagnostic accuracy and treatment outcomes for patients while supporting healthcare providers with efficient and precise tools. The company is headquartered in Nashua, New Hampshire, and its shares are listed on the NASDAQ.
Key slides for iCAD Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ICAD
Country
🇺🇸 United States